Metacavir is an orally active, potent and specific nucleoside reverse transcriptase inhibitor against hepatitis B virus (HBV) with antiviral activity[1].
References
[1] Zhang P, et al. In vitro mitochondrial toxicity of metacavir, a new nucleoside reverse transcriptase inhibitor for treatment of hepatitis B virus. Antimicrob Agents Chemother. 2010 Nov;54(11):4887-92. DOI:10.1128/AAC.00794-10
